Login / Signup

Long-term follow-up of patients undergoing renal sympathetic denervation.

Victor J M ZeijenJoost DaemenRajiv Nannan PandayKevin M VeenJorie VersmissenIsabella KardysNicolas M D A van MieghemJoost Daemen
Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2022)
The BP-lowering effect of RDN was safely maintained at least five years post-procedure as reflected by a significant decrease in ambulatory daytime BP in the absence of escalating antihypertensive drug therapy over time.
Keyphrases
  • blood pressure
  • patients undergoing
  • obstructive sleep apnea
  • minimally invasive
  • hypertensive patients
  • sleep quality
  • stem cells
  • adverse drug
  • drug induced
  • physical activity
  • cell therapy
  • mesenchymal stem cells